HIV-1 is responsible for the development of a spectrum of cognitive impairments known as
HIV-associated neurocognitive disorder (HAND). In the era of antiretroviral therapy (ART) …

In recent years, there have been many exciting developments in the biomedical applications
of the macrophage membrane bionic drug delivery system (MM-Bio-DDS). Macrophages, as …

Multiple lines of evidence indicate that patients with chronic schizophrenia (SCZ) display
executive dysfunction across the illness course. However, the potential molecular …

Human immunodeficiency virus-associated neurocognitive impairment (HANI) remains
problematic despite the effective use of antiretroviral therapy (ART) and viral suppression. A …

Highly active antiretroviral therapy (HAART) comprises a combination of two or three
antiretroviral (ARV) drugs that are administered together in a single tablet. These drugs …

Background: The aim of this study was to review the clinical data on the effectiveness of the
pharmacotherapy of HIV-associated neurocognitive disorders (HANDs). Methods: A …

Low and middle-income countries (LMICs) are the epicenter of the HIV epidemic. The scale-
up of antiretroviral therapy (ART) has reduced mortality, but HIV-associated neurocognitive …

Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) remains
prevalent in the anti-retroviral (ART) era. While there is a complex interplay of many factors …

A spectrum of cognitive impairments known as HIV-associated neurocognitive disorders
(HAND) are consequences of the effects of HIV-1 within the central nervous system …

This study investigates the association between serum mature brain-derived neurotrophic
factor (mBDNF), its precursor proBDNF, and neurocognitive function in ART-naïve adults …